Investigator-initiated trials (IITs)
Investigator-initiated trials (IITs) support independent investigators and academic sponsors conducting clinical and non-clinical research to advance knowledge about Lundbeck compounds and improve patients’ lives.
Funder: Lundbeck
Due Dates: Rolling (monthly review)
Funding Amounts: Research grants and/or study materials; requests assessed against local fair market value
Summary: Supports independent clinical and non-clinical research addressing medical and scientific questions about Lundbeck compounds.
Key Information: Studies must be unsolicited and developed and sponsored independently of Lundbeck.
Description
Lundbeck’s investigator-initiated trials (IITs) program supports ethical, independent research intended to advance medical and scientific knowledge and improve patients’ lives. It covers clinical trials, non-interventional studies and preclinical research developed and sponsored by independent investigators or academic sponsors. Lundbeck may provide a research grant, study materials, validation of study design, or a combination of these.
Proposals should address legitimate medical or scientific questions affecting the use of Lundbeck’s marketed products or investigational compounds. Interests include understanding a compound’s risk-benefit profile, addressing unmet medical needs and complementing Lundbeck’s research and development plans. Requests outside the areas of interest shown on the program page generally will not be considered.
